Specifically, macrophage-specific METTL14 deficiency can trigger significant functional impairment in tumor-infiltrating CD8+ T cells, characterized by compromised effector cytokine production and the marked upregulation of exhaustion-associated checkpoints. This evidence concerns the gene CD8A and neoplasm.